Torres, Antoni http://orcid.org/0000-0002-8643-2167
Chalmers, James D.
Dela Cruz, Charles S.
Dominedò, Cristina
Kollef, Marin
Martin-Loeches, Ignacio
Niederman, Michael
Wunderink, Richard G.
Article History
Received: 15 October 2018
Accepted: 4 January 2019
First Online: 31 January 2019
Compliance with ethical standards
:
: Professor Torres is consultant for Pfizer, Bayer, Roche, MSD, Polyphor. Professor Chalmers reports grants and personal fees from Glaxosmithkline, grants and personal fees from Boehringer-Ingelheim, grants from Astrazeneca, grants and personal fees from Pfizer, grants and personal fees from Bayer Healthcare, grants and personal fees from Grifols, personal fees from Napp, personal fees from Aradigm corporation, grants and personal fees from Insmed, outside the submitted work. Professor Dela Cruz declares no conflict of interest. Doctor Dominedò declares no conflict of interest. Professor Kollef was supported by the Barnes-Jewish Hospital Foundation. Doctor Martin-Loeches declares no conflict of interest. Professor Niederman is consultant for Pfizer, Merck, Paratek and Melinta. Professor Wunderink is consultant for Nabriva, Melinta, bioMerieux, Curetis, Genmark, Accelerate.
: An approval by an ethics committee was not applicable.
Free to read: This content has been made available to all.